All News

Atea’s drug candidate is considered safe and effective against the viruses that cause COVID-19 and hepatitis C, according to new data presented at ICAR 2023.

Therapy effectively treats cells harboring HR deficiencies, including those of specific types of ovarian, breast cancers.

Clinical decision support, packaging changes can help stop errors related to the HIV medication.

Findings from the ongoing Adult Respiratory Syncytial Virus phase 3 trial suggest RSVPreF3 OA vaccine is effective and safe for individuals aged 60 years and older.

Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.

Most patients used nonproprietary drugs, which may contribute to the reduction of out-of-pocket costs for the treatment of invasive breast cancer.

This month, we spoke with Danielle Roman, PharmD, an oncology clinical pharmacy specialist with Allegheny Health Network.

The treatment shows an acceptable toxicity profile and no new adverse events, according to results of analysis.

Niraparib with abiraterone acetate could be the first dual-action tablet for patients with metastatic castration-resistant prostate cancer and BRCA mutations.

The kit is now approved in the US to select patients with metastatic prostate cancer who are candidates for the only FDA-approved PSMA-directed radioligand therapy.

Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.

Clostridioides difficile infection can have a significant impact on feelings of depression and anxiety, while worsening quality of life.

Liquid formulations of dabrafenib plus trametinib were also approved, marking the first time a BRAF/MEK inhibitor has been developed in a formulation suitable for patients as young as 1 year of age.

Staff members, especially immunizers, should look at every encounter as an opportunity to educate, support patients.

Indya Wilson, MBA, CPhT, a pharmacy education support specialist at Novant Health Pharmacy Administration, discusses her role in the pharmacy and the benefits of alternative career paths for pharmacy technicians.

MenABCWY combination meets all 11 primary endpoints and shows that it is well tolerated, with a safety profile consistent with MenACWY (Menveo) and MenB (Bexsero).

The risk of long COVID-19 was no worse for patients who had Omicron after the wild-type virus than those just diagnosed with the wild-type.

Continued advancements in therapy may expand its use to larger patient population, though challenges remain

At 1 year, patients receiving chemotherapy regimens containing anthracyclines for lymphoma who took statins had an average ejection fraction that was 1.3% higher than those who took placebo.

Following this year’s Match Day on March 15, pharmacists at US Pharmacopeia (USP) explain some of the opportunities student pharmacists can pursue outside of the traditional pharmacy career model.

Carlene Link, PharmD, BCPS, a clinical pharmacist, discusses career wellness.

Navigating insurance presents a challenge, but pharmacists improve stakeholder access and provide in-home care.

Trastuzumab deruxtecan was approved by the FDA for HER2-low breast cancer treatment in 2022 and could also benefit some patients with hormone receptor-positive or triple-negative disease.

Providers who are sensitive to health literacy have contributed to positive quality improvement across various institutions.

Educate patients about the use of nonprescription products for digestive issues, and encourage them to seek further medical care when warrented.

Among the participants who were initially unsure or hesitant about vaccination, 82% received flu and Tdap vaccines during pregnancy after the online intervention.

This episode features Bruce Berger, PhD, president of Berger Consulting, LLC, who discusses how pharmacists should best use motivational interviewing with patients.

Osimertinib (Tagrisso; AstraZeneca) now has shown a statistically significant and clinically meaningful overall survival benefit in both the early adjuvant and late-stage metastatic settings.